Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial

Table 5 Blood pressure changes of placebo and PP during the intervention

Variables		Before	P *	Middle	After	Changes	P Group	P time	P Group x time	P **
Systolic Blood Pressure (cmHg)	Placebo	13.50 ± 1.21	0.01	13.40 ± 1.14	13.30 ± 1.15	-0.16 ± 0.19	0.65	< 0.001	< 0.001	< 0.001
Systolic Blood Pressure (cmHg)	PP	14.30 ± 1.48	0.01	13.90 ± 1.44	13.60 ± 1.40	-0.63 ± 0.29	0.65	< 0.001	< 0.001	< 0.001
Diastolic Blood Pressure (cmHg)	Placebo	8.50 ± 0.74	0.05	8.50 ± 0.70	8.40 ± 0.70	-0.09 ± 0.16	0.23	< 0.001	< 0.001	< 0.001
Diastolic Blood Pressure (cmHg)	PP	8.90 ± 0.76	0.05	8.70 ± 0.77	8.50 ± 0.75	-0.39 ± 0.19	0.23	< 0.001	< 0.001	< 0.001

Data is presented as Mean ± SD.
P* is extracted from 2 independent sample t test, and P** is presented adjusted model by baseline values, energy intake and physical activity, with ANCOVA. Also, P for group, time and group x time is extracted from repeated measures for raw model.
“Changes” represent before and after changes in raw model. “PP” is for Pomegranate Peel group. cmHg: Centimeters of Mercury

ISSN: 1475-2891